The head of the Community Liver Alliance (CLA) said this week that the federal 340b drug discount program has “gone astray” from its original mission, citing the number of New Y work 340b hospitals located in “underserved” communities.
A government waste watchdog group said a federal drug discount program in which 128 New York hospitals participate is a “mess” and needs more oversight.
Spending on prescription drugs purchased at participating health care providers through the federal 340b drug discount program increased 19% annually between 2010 and 2021.
The president of the National Pharmaceutical Council (NPC) said patients served by the hospitals participating in a federal drug discount program might not actually be receiving the intended discounts from that program. 111 NY hospitals participate in that program.
A national health policy analyst said New York patients served by a hospital participating in the federal 340b drug program should be concerned the drug savings aren’t being passed along to them.